JPMorgan Chase & Co’s Icosavax, Inc. Common Stock ICVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-29,594
| Closed | -$466K | – | 6806 |
|
|
2023
Q4 | $466K | Buy |
29,594
+10,765
| +57% | +$170K | ﹤0.01% | 3952 |
|
|
2023
Q3 | $146K | Sell |
18,829
-2,664
| -12% | -$20.6K | ﹤0.01% | 4410 |
|
|
2023
Q2 | $213K | Buy |
21,493
+4,328
| +25% | +$43K | ﹤0.01% | 4243 |
|
|
2023
Q1 | $100K | Buy |
17,165
+1,986
| +13% | +$11.6K | ﹤0.01% | 4653 |
|
|
2022
Q4 | $121K | Sell |
15,179
-540
| -3% | -$4.31K | ﹤0.01% | 4423 |
|
|
2022
Q3 | $50K | Sell |
15,719
-46,764
| -75% | -$149K | ﹤0.01% | 4709 |
|
|
2022
Q2 | $358K | Buy |
62,483
+42,935
| +220% | +$246K | ﹤0.01% | 4047 |
|
|
2022
Q1 | $138K | Buy |
19,548
+7,883
| +68% | +$55.7K | ﹤0.01% | 4615 |
|
|
2021
Q4 | $268K | Buy |
11,665
+6,737
| +137% | +$155K | ﹤0.01% | 4386 |
|
|
2021
Q3 | $146K | Buy |
+4,928
| New | +$146K | ﹤0.01% | 4547 |
|